Projects funded by the NCN
Oxidation products of 5-methylcytosine as a new predictive markers for respons to systemic chemotherapy of breast cancer.
2015/17/B/NZ5/00640
Keywords:
5-methylcytosine active DNA demethylation breast cancer chemotherapy
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
- NZ2_2: Genomics, transcriptomics, epigenomics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy
woj. kujawsko-pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 13
Call: OPUS 9 - announced on 2015-03-16
Amount awarded: 1 388 000 PLN
Project start date (Y-m-d): 2016-04-06
Project end date (Y-m-d): 2020-04-05
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.